NIBR is relaunching its Neuroscience group in Cambridge to focus on innovative science that leads to the discovery and development of new drugs for neuropsychiatric and neurodegenerative diseases.
Researchers have many opportunities for growth and recognition. We value innovation, especially when it elucidates the patho-physiology of diseases, leads to new drug targets, and generates new technologies.
We are driven by rigorous science and unmet medical need, not the market. NIBR does great science. Working at NIBR gives you a very real chance of making a difference in patients' lives. This is something that most academics never really come close to.